Physician profile
Marta E Taylor
NPI 1891002549
$470.28
in general payments reported to CMS, 2019-2025
12 companies · $68.46 in 2025
The $68.46 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.19 · 2022: $87.94 · 2023: $49.53 · 2024: $218 · 2025: $68.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $198.06 | 2022-2024 | Veozah |
| Biogen, INC. | $44.91 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $43.36 | 2024-2025 | Fluent Fluid Management System, Novasure, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $36.24 | 2024 | Ova1 |
| Napo Pharmaceuticals INC | $33.18 | 2021 | |
| Coopersurgical, INC. | $18.61 | 2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $18.51 | 2024 | |
| Janssen Pharmaceuticals, INC | $18.01 | 2023 | Spravato |
| Viiv Healthcare Company | $17.05 | 2023 | Apretude |
| Glaxosmithkline, LLC. | $14.87 | 2022 | |
| Cranial Technologies, INC | $14.47 | 2023 | Doc Band |
| Urovant Sciences INC | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.